Reflections on the changing face of German pharmaceutical policy: how far is Germany from value-based pricing?

Pharmacoeconomics. 2011 Jul;29(7):549-53. doi: 10.2165/11592580-000000000-00000.

Authors

Andreas Gerber¹, Stephanie Stock, Charalabos-Markos Dintsios

Affiliation

¹ Institute for Quality and Efficiency in Health Care, Cologne, Germany. andreas.gerber@iqwig.de

PMID: 21671685
DOI: 10.2165/11592580-000000000-00000

No abstract available

MeSH terms

Drug Costs / trends*
Germany
Humans
Insurance, Pharmaceutical Services / economics
Insurance, Pharmaceutical Services / trends
Pharmaceutical Preparations / economics*
Rate Setting and Review / methods*
Rate Setting and Review / trends
Reimbursement Mechanisms / economics
Reimbursement Mechanisms / trends

Substances

Pharmaceutical Preparations